Company Shares of Stereotaxis (NASDAQ:STXS) Rally 27.53%

Stereotaxis (NASDAQ:STXS) : Traders are bullish on Stereotaxis (NASDAQ:STXS) as it has outperformed the S&P 500 by a wide margin of 5.98% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 25.92%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 27.53% in the last 1 week, and is up 7.69% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.

The company shares have dropped -14.29% from its 1 Year high price. On Aug 28, 2015, the shares registered one year high at $2.53 and the one year low was seen on Jan 20, 2016. The 50-Day Moving Average price is $1.10 and the 200 Day Moving Average price is recorded at $1.08.

The stock has recorded a 20-day Moving Average of 22.51% and the 50-Day Moving Average is 5.88%.


Stereotaxis (NASDAQ:STXS): stock turned positive on Friday. Though the stock opened at $1.13, the bulls momentum made the stock top out at $1.45 level for the day. The stock recorded a low of $1.05 and closed the trading day at $1.26, in the green by 24.75%. The total traded volume for the day was 1,004,430. The stock had closed at $1.01 in the previous days trading.

In an insider trading activity, The director, of Stereotaxis, Inc., Middleton Fred A had unloaded 26,064 shares at $1.57 per share in a transaction on June 15, 2015. The total value of transaction was $40,920. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.

Stereotaxis, Inc. (Stereotaxis) designs, manufactures and markets robotic systems and instruments for use primarily by electrophysiologists for the treatment of abnormal heart rhythms known as cardiac arrhythmias. The Company offers its Epoch Solution, a remote robotic navigation system for use in a hospitals interventional surgical suite or interventional lab. The Epoch Solution consists of the Niobe ES Robotic Magnetic Navigation System (Niobe ES system), Odyssey Information Management Solution (Odyssey Solution) and the Vdrive Robotic Navigation System (Vdrive system). The components of the Niobe system include Niobe Remote Magnetic Navigation System and Cardiodrive Automated Catheter Advancement System. The Odyssey Solution offers a real-time information solution to manage, control, record and share procedures across networks or around the world. The Vdrive system provides navigation and stability for diagnostic and ablation devices.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.